Creative Medical Technology Holdings, Inc. (CELZ) Financial Statements (2024 and earlier)

Company Profile

Business Address 211 E. OSBORN RD.
PHOENIX, AZ 85012
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18,39910,724988930414
Cash and cash equivalents18,39910,724988930414
Receivables    6105
Inventory, net of allowances, customer advances and progress billings1011    
Inventory1011    
Other undisclosed current assets3382    
Total current assets:18,74710,737989431418
Noncurrent Assets
Intangible assets, net (including goodwill)436528620437164185
Intangible assets, net (excluding goodwill)436528620437164185
Other undisclosed noncurrent assets33    
Total noncurrent assets:439531620437164185
TOTAL ASSETS:19,18611,268718531477203
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,307786511441353261
Accounts payable3,268762351321332238
Accrued liabilities40241601202223
Debt   7891,062682377
Derivative instruments and hedges, liabilities   38,7426,8483,2271,309
Due to related parties141411111111
Other undisclosed current liabilities 250469240198478
Total current liabilities:3,3221,05040,5218,6024,4722,435
Noncurrent Liabilities
Long-term debt and lease obligation      1
Long-term debt, excluding current maturities      1
Liabilities, other than long-term debt      3
Accounts payable and accrued liabilities      3
Total noncurrent liabilities:      4
Total liabilities:3,3221,05040,5218,6024,4722,439
Equity
Equity, attributable to parent, including:15,86510,218(39,803)(8,071)(3,995)(2,236)
Common stock14676922903115
Treasury stock, value      
Additional paid in capital69,66253,87921,31617,46812,1811,075
Accumulated deficit(53,812)(43,668)(61,890)(25,565)(17,081)(3,426)
Other undisclosed equity, attributable to parent   333 
Total equity:15,86510,218(39,803)(8,071)(3,995)(2,236)
TOTAL LIABILITIES AND EQUITY:19,18611,268718531477203

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues89881651661245
Other income100     
Cost of revenue(28)(48)(51)(45)(70)(8)
Gross profit:604011412054(3)
Operating expenses(10,304)(3,166)(1,229)(1,250)(1,168)(1,175)
Operating loss:(10,244)(3,126)(1,115)(1,130)(1,114)(1,178)
Nonoperating income (expense)10022,338(35,210)(7,354)(12,541)(1,481)
Interest and debt expense 586(1,230)(366)408(378)
Income (loss) from continuing operations before equity method investments, income taxes:(10,144)19,797(37,555)(8,850)(13,247)(3,037)
Other undisclosed income (loss) from continuing operations before income taxes (586)1,230366(408) 
Income (loss) from continuing operations:(10,144)19,212(36,325)(8,484)(13,656)(3,037)
Income (loss) before gain (loss) on sale of properties:19,212(36,325)(8,484)(13,656)(3,037)
Other undisclosed net loss      
Net income (loss):(10,144)19,212(36,325)(8,484)(13,656)(3,037)
Other undisclosed net income attributable to parent     378
Net income (loss) attributable to parent:(10,144)19,212(36,325)(8,484)(13,656)(2,659)
Preferred stock dividends and other adjustments  (197)    
Other undisclosed net income available to common stockholders, basic  197    
Net income (loss) available to common stockholders, basic:(10,144)19,212(36,325)(8,484)(13,656)(2,659)
Other undisclosed net loss available to common stockholders, diluted  (989)    
Net income (loss) available to common stockholders, diluted:(10,144)18,222(36,325)(8,484)(13,656)(2,659)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(10,144)19,212(36,325)(8,484)(13,656)(3,037)
Comprehensive income (loss), net of tax, attributable to parent:(10,144)19,212(36,325)(8,484)(13,656)(3,037)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: